Chemed (CHE) Competitors $440.10 +9.18 (+2.13%) Closing price 10/17/2025 03:59 PM EasternExtended Trading$440.56 +0.46 (+0.11%) As of 07:21 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock CHE vs. MEDP, LH, DGX, DVA, CRVL, MD, AMN, CCRN, EHC, and ELANShould you be buying Chemed stock or one of its competitors? The main competitors of Chemed include Medpace (MEDP), Labcorp (LH), Quest Diagnostics (DGX), DaVita (DVA), CorVel (CRVL), Pediatrix Medical Group (MD), AMN Healthcare Services (AMN), Cross Country Healthcare (CCRN), Encompass Health (EHC), and Elanco Animal Health (ELAN). Chemed vs. Its Competitors Medpace Labcorp Quest Diagnostics DaVita CorVel Pediatrix Medical Group AMN Healthcare Services Cross Country Healthcare Encompass Health Elanco Animal Health Chemed (NYSE:CHE) and Medpace (NASDAQ:MEDP) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, profitability, analyst recommendations, institutional ownership, media sentiment, dividends, valuation and earnings. Does the media refer more to CHE or MEDP? In the previous week, Medpace had 13 more articles in the media than Chemed. MarketBeat recorded 19 mentions for Medpace and 6 mentions for Chemed. Chemed's average media sentiment score of 1.58 beat Medpace's score of 0.97 indicating that Chemed is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Chemed 5 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Medpace 13 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do institutionals and insiders believe in CHE or MEDP? 95.9% of Chemed shares are owned by institutional investors. Comparatively, 78.0% of Medpace shares are owned by institutional investors. 3.3% of Chemed shares are owned by insiders. Comparatively, 20.3% of Medpace shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Which has higher earnings and valuation, CHE or MEDP? Medpace has lower revenue, but higher earnings than Chemed. Chemed is trading at a lower price-to-earnings ratio than Medpace, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioChemed$2.43B2.64$302M$19.4522.63Medpace$2.11B7.03$404.39M$13.4539.26 Is CHE or MEDP more profitable? Medpace has a net margin of 18.74% compared to Chemed's net margin of 11.56%. Medpace's return on equity of 67.66% beat Chemed's return on equity.Company Net Margins Return on Equity Return on Assets Chemed11.56% 25.83% 17.77% Medpace 18.74%67.66%21.86% Which has more volatility and risk, CHE or MEDP? Chemed has a beta of 0.43, meaning that its share price is 57% less volatile than the S&P 500. Comparatively, Medpace has a beta of 1.4, meaning that its share price is 40% more volatile than the S&P 500. Do analysts prefer CHE or MEDP? Chemed presently has a consensus target price of $578.50, indicating a potential upside of 31.45%. Medpace has a consensus target price of $430.60, indicating a potential downside of 18.46%. Given Chemed's stronger consensus rating and higher probable upside, analysts clearly believe Chemed is more favorable than Medpace.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Chemed 0 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.80Medpace 3 Sell rating(s) 12 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 1.94 SummaryMedpace beats Chemed on 9 of the 16 factors compared between the two stocks. Get Chemed News Delivered to You Automatically Sign up to receive the latest news and ratings for CHE and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CHE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CHE vs. The Competition Export to ExcelMetricChemedMED IndustryMedical SectorNYSE ExchangeMarket Cap$6.41B$4.32B$6.13B$21.77BDividend Yield0.54%1.24%5.72%3.63%P/E Ratio22.6330.1629.3432.43Price / Sales2.64287.68595.2781.20Price / Cash17.1428.2625.8218.06Price / Book5.924.7712.224.59Net Income$302M$197.51M$3.33B$1.01B7 Day Performance2.54%4.04%0.62%-0.38%1 Month Performance-2.67%5.94%6.82%-0.93%1 Year Performance-27.87%28.02%58.78%9.46% Chemed Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CHEChemed4.9836 of 5 stars$440.10+2.1%$578.50+31.4%-27.9%$6.41B$2.43B22.6315,695Positive NewsMEDPMedpace4.2815 of 5 stars$527.40+5.2%$422.27-19.9%+48.2%$14.08B$2.11B39.215,900Upcoming EarningsAnalyst ForecastLHLabcorp4.4157 of 5 stars$276.37-0.5%$292.00+5.7%+32.4%$23.09B$13.01B30.5070,000Positive NewsAnalyst ForecastDGXQuest Diagnostics4.6902 of 5 stars$182.81-0.7%$186.63+2.1%+26.8%$20.58B$9.87B21.8956,000Positive NewsUpcoming EarningsAnalyst ForecastDVADaVita4.8808 of 5 stars$123.89-0.1%$155.25+25.3%-22.3%$8.87B$12.82B12.1876,000CRVLCorVel1.0777 of 5 stars$71.41-1.7%N/A-31.4%$3.73B$895.59M36.815,075MDPediatrix Medical Group1.5301 of 5 stars$16.06+1.6%$16.79+4.5%+29.3%$1.38B$2.01B12.454,305AMNAMN Healthcare Services4.3398 of 5 stars$19.14+5.4%$23.08+20.6%-52.1%$695.97M$2.98B-2.462,968Short Interest ↓Analyst RevisionCCRNCross Country Healthcare3.8023 of 5 stars$12.50+7.9%$17.93+43.4%-1.9%$379.71M$1.34B-48.088,205EHCEncompass Health4.8307 of 5 stars$121.35-0.7%$139.86+15.2%+28.2%$12.30B$5.37B23.7540,000ELANElanco Animal Health2.5557 of 5 stars$20.04+1.4%$19.14-4.5%+65.2%$9.82B$4.44B23.309,000 Related Companies and Tools Related Companies Medpace Alternatives Labcorp Alternatives Quest Diagnostics Alternatives DaVita Alternatives CorVel Alternatives Pediatrix Medical Group Alternatives AMN Healthcare Services Alternatives Cross Country Healthcare Alternatives Encompass Health Alternatives Elanco Animal Health Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:CHE) was last updated on 10/20/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredThis Crypto Is Set to Explode in JanuaryCurious about crypto but still stuck scrolling endless threads? People who get in early aren’t just lucky—they...Crypto 101 Media | SponsoredElon Musk is on the lineElon Musk says November 6 could "affect the future of the world" Get ready for the biggest pivot in corpora...Altimetry | SponsoredThe 7 Warning Signals Flashing Red Right NowA free report revealing the 7 key indicators that have predicted every major economic collapse since 1929. ...American Alternative | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredBlackRock’s Shocking Crypto MoveBlackRock, Fidelity, and JPMorgan have quietly shifted billions out of Bitcoin and into a single emerging cryp...Weiss Ratings | Sponsored$15 Fund: Turn Gold Boom into Real IncomeIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Chemed Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Chemed With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.